Unless stated all financials at 31 December 2025
£1.06bn
Net assets
173.9p
NAV per share
1.8%
NAV per share return in the nine months
£840m
Value of life science portfolio
3.3%
Return from life science portfolio in the nine months
£218m
Capital pool